thrombosis disease
Conditions
Interventions
Test Group:POCT device was used to detect PT/INR at home, and anticoagulation management program was used for anticoagulation management
Control Group:The PT/INR was detected in the hospital, and the anticoagulation adjustment was guided by the doctor or clinical pharmacist according to the INR results.
Sponsors
Peking University Shenzhen Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Patients who need warfarin after artificial heart valve replacement, atrial fibrillation, cerebral infarction, venous thromboembolism, etc.; 2. Age 18 years or older, both sexes; 3. All patients and their family members signed informed consent voluntarily; 4. Warfarin was administered during the trial period.
Exclusion criteria
Exclusion criteria: 1. Patients with previous mental illness or cognitive, language and communication disorders; 2. Patients with malignant tumors and complicated with other anticoagulant and antiplatelet agglutination drugs; 3. Patients with other coagulation diseases; 4. Women preparing for pregnancy, pregnancy or lactation during the test cycle.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| prothrombin time;prothrombin time; | — |
Countries
China
Contacts
Public ContactLei Huang
Peking University Shenzhen Hospital
Outcome results
None listed